Colorectal
-
Facebook
-
Twitter
-
Linkedin
Learn about colorectal health, including prevention, screening, and treatment options for colorectal diseases. Stay informed on the latest advancements in colorectal cancer research.

Mission Cancer + Blood opens new clinic in Waukee
WAUKEE, Iowa Ñ Cancer care is expanding to the west of the metro. On Monday, Mission Cancer + Blood opened a new clinic in Waukee.

New drug shows promise in treating childhood bone cancer
A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield.

Common malaria drug repurposed to fight cancer
Can a drug that’s used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years.

Colorectal cancer can be detected, eliminated with early and proper testing – don’t wait
Screening for colon cancer saves lives. This March, during Colorectal Cancer Awareness Month, talk with your provider about a colonoscopy screening.

A protein from tiny tardigrades may help cancer patients tolerate radiation therapy
About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this radiation can have severe side effects that often end up being too difficult for patients to tolerate.

Pancreatic cancer RNA vaccine shows durable T cell immunity
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8+ T cells in patients with pancreatic ductal adenocarcinoma (PDAC), potentially delaying disease recurrence.

Tardigrade proteins show promise in cancer care
Patients undergoing radiation therapy experience debilitating side effects because of toxicity arising from radiation-induced DNA strand breaks in normal peritumoral cells.

Combining protein therapy and focused ultrasound therapy can improve cancer treatment
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) with focused ultrasound (FUS) can significantly reduce tumor size and burden in prostate cancer models, according to a new study published in Advanced Science by researchers at Rice University and Vanderbilt University.

Higher Calcium Intake Linked to Reduced Colorectal Cancer Risk
Finding was consistent across calcium sources and tumor sites

Testosterone Recovery Linked to Overall Survival in High-Risk Prostate Cancer
TUESDAY, Feb. 18, 2025 (HealthDay News) — Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients with high-risk prostate cancer receiving radiotherapy and long-term androgen deprivation therapy (ADT), according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb. 13 to 15 in San Francisco.
Genetically altered mice shed light on skin cancer
Research in Asia and Europe has provided further insights into how disruption to communication between the gut and brain could have an effect on anxiety levels and diseases such as Alzheimer’s.

Uncovering inequalities in breast cancer immunotherapy access
The study examines trends in immunotherapy treatment for triple-negative breast cancer since the new therapies were approved.